share_log

Vita Life Sciences Limited (ASX:VLS) Raises Dividend to $0.03 Per Share

kopsource ·  Mar 15, 2023 17:30

Vita Life Sciences Limited (ASX:VLS – Get Rating) announced a final dividend on Wednesday, March 15th, MarketIndexAU reports. Shareholders of record on Thursday, April 13th will be paid a dividend of 0.033 per share on Thursday, April 13th. This represents a yield of 2.08%. The ex-dividend date of this dividend is Thursday, March 16th. This is an increase from Vita Life Sciences's previous final dividend of $0.03.

Vita Life Sciences Price Performance

The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.57 and a current ratio of 2.77.

Get Vita Life Sciences alerts:

About Vita Life Sciences

(Get Rating)

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints.

Recommended Stories

  • SentinelOne: Reversal In-Play For Cybersecurity Stocks
  • Is Sportradar Group A Growth Stock To Bet On In 2023?
  • Strong Guidance says Boeing is Ready for Takeoff
  • Lennar Raises The Roof With Q1 Results: Don't Chase It Higher
  • Universal Insurance: Navigating Florida's Insurance Crisis

Receive News & Ratings for Vita Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vita Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment